Septicemia in neutropenic patients infected with Clostridium tertium resistant to cefepime and other expanded-spectrum cephalosporins
- PMID: 10523601
- PMCID: PMC85761
- DOI: 10.1128/JCM.37.11.3778-3779.1999
Septicemia in neutropenic patients infected with Clostridium tertium resistant to cefepime and other expanded-spectrum cephalosporins
Abstract
Clostridium tertium was isolated from two immunocompromised patients with septicemia, fever, and gastrointestinal symptoms. The strains were resistant to ceftazidime, cefepime, and clindamycin; intermediately resistant to penicillin; and susceptible to metronidazole, quinolones, and vancomycin.
References
-
- Cato E P, George W L, Finegold S M. Clostridium. In: Sneath P H A, Mair N S, Sharpe M E, Holt J G, editors. Bergey's manual of systematic bacteriology. Vol. 2. Baltimore, Md: The Williams and Wilkins Co.; 1986. pp. 1141–1200.
-
- EORTC International Antimicrobial Therapy Cooperation Group. Ceftazidime combined with a short or long course of amikacin for empirical therapy of Gram-negative bacteremia in cancer patients with granulocytopenia. N Engl J Med. 1987;317:1692–1698. - PubMed
-
- Gosbell I B, Johnson C G, Newton P J, Jelfs J. Clostridium tertium bacteremia: 2 cases and review. Pathology. 1996;28:70–73. - PubMed
-
- Johnson J R, Tenover F C. Clostridium tertium bacteremia in a patient with aspiration pneumonia: an elusive diagnosis. J Infect Dis. 1988;157:854–855. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
